Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 364

1.

Predicting 15-year prostate cancer specific mortality after radical prostatectomy.

Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.

J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.

2.

Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality.

Stephenson AJ, Eggener SE, Hernandez AV, Klein EA, Kattan MW, Wood DP Jr, Rabah DM, Eastham JA, Scardino PT.

Eur Urol. 2014 Apr;65(4):675-80. doi: 10.1016/j.eururo.2013.08.036. Epub 2013 Aug 27.

PMID:
24035631
3.

Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.

Eastham JA, Scardino PT, Kattan MW.

J Urol. 2008 Jun;179(6):2207-10; discussion 2210-1. doi: 10.1016/j.juro.2008.01.106. Epub 2008 Apr 18.

4.
5.

Positive surgical margins after radical prostatectomy: a systematic review and contemporary update.

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K.

Eur Urol. 2014 Feb;65(2):303-13. doi: 10.1016/j.eururo.2013.07.039. Epub 2013 Aug 3. Review.

PMID:
23932439
6.

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Yossepowitch O, Eggener SE, Serio AM, Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA.

Eur Urol. 2008 May;53(5):950-9. Epub 2007 Oct 12.

7.

Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.

Yossepowitch O, Eggener SE, Bianco FJ Jr, Carver BS, Serio A, Scardino PT, Eastham JA.

J Urol. 2007 Aug;178(2):493-9; discussion 499. Epub 2007 Jun 11.

PMID:
17561152
8.

Role of radical prostatectomy in the treatment of high-risk prostate cancer.

Yossepowitch O, Eastham JA.

Curr Urol Rep. 2008 May;9(3):203-10. Review.

PMID:
18765114
9.

Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.

Eggener SE, Yossepowitch O, Serio AM, Vickers AJ, Scardino PT, Eastham JA.

Urology. 2007 Jun;69(6):1128-33.

PMID:
17572200
10.

The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.

Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT.

Eur Urol. 2007 Apr;51(4):940-7; discussion 947-8. Epub 2006 Oct 30.

11.

Radical prostatectomy for high-risk prostate cancer.

Yossepowitch O, Eastham JA.

World J Urol. 2008 Jun;26(3):219-24. doi: 10.1007/s00345-008-0247-2. Epub 2008 Mar 12. Review.

PMID:
18335221
12.

Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.

Masterson TA, Stephenson AJ, Scardino PT, Eastham JA.

Urology. 2005 Sep;66(3):623-6.

PMID:
16140090
13.

Is year of radical prostatectomy a predictor of outcome in prostate cancer?

Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F, Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen M, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW.

J Urol. 2004 Feb;171(2 Pt 1):692-6.

PMID:
14713788
14.

Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.

Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA.

J Urol. 2006 Aug;176(2):564-8.

PMID:
16813890
15.

Variations among experienced surgeons in cancer control after open radical prostatectomy.

Bianco FJ Jr, Vickers AJ, Cronin AM, Klein EA, Eastham JA, Pontes JE, Scardino PT.

J Urol. 2010 Mar;183(3):977-82. doi: 10.1016/j.juro.2009.11.015. Epub 2010 Jan 18.

16.

Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.

Berglund RK, Stephenson AJ, Cronin AM, Vickers AJ, Eastham JA, Klein EA, Guillonneau BD.

Urology. 2009 May;73(5):1098-103. doi: 10.1016/j.urology.2008.07.052. Epub 2009 Mar 17.

17.

Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.

Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA.

J Urol. 2004 Dec;172(6 Pt 1):2239-43.

PMID:
15538239
18.

Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.

Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, Carver BS.

J Urol. 2009 Oct;182(4):1357-63. doi: 10.1016/j.juro.2009.06.046. Epub 2009 Aug 14.

PMID:
19683274
19.

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.

Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT.

J Urol. 2005 Sep;174(3):903-7.

PMID:
16093984
20.

A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B.

J Urol. 2009 Apr;181(4):1635-41; discussion 1641. doi: 10.1016/j.juro.2008.11.109. Epub 2009 Feb 23.

Supplemental Content

Support Center